Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Stride Raises FY2025 Sales Guidance from $2.32B-$2.35B to $2.37B-$2.38B vs $2.34B Est

Author: Benzinga Newsdesk | April 29, 2025 04:17pm
Stride (NYSE:LRN) raises FY2025 sales outlook from $2.32 billion-$2.35 billion to $2.37 billion-$2.38 billion vs $2.34 billion estimate.

Posted In: LRN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist